HMC's Cardio-Oncology Program providing unique services to patients
Doha, Qatar: Hamad Medical Corporation s pioneering Cardio Oncology Program aims to become a beacon of excellence in the Middle East and beyond. The p...
Stay updated with breaking news from Oncology Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Doha, Qatar: Hamad Medical Corporation s pioneering Cardio Oncology Program aims to become a beacon of excellence in the Middle East and beyond. The p...
Ocean Biomedical Inc (NASDAQ: OCEA) shared an update on its broad range of programs in malaria, fibrosis, and multiple cancers. Oncology Program:
Company receives further regulatory clarity from FDA on Phase 3 ENABLAR-2 study. Potential for enobosarm +/- abemaciclib accelerated approval pathway in metastatic breast cancer, if successful based... -Today at 06:31 am- MarketScreener
- Recently presented 36-month apitegromab extension data from Phase 2 TOPAZ trial demonstrate long-term substantial and sustained improvement of motor function and further strengthen conviction in...
David Ziegler, MD, PhD, discusses findings from the phase 2 FIREFLY-1 trial of tovorafenib in pediatric patients with low-grade glioma.